KADCYLA for previously treated HER2 Metastatic Breast Cancer

Learn about KADCYLA ado-trastuzumab emtansine, a treatment option for HER2-positive breast cancer. Who is KADCYLA for? KADCYLA is approved to treat HER2-positive breast cancer that has spread to other parts of the body metastatic breast cancer after prior treatment with trastuzumab Herceptin and a taxane. Prior treatment could have been for the initial treatment of breast cancer or for the treatment of cancer that had spread to other parts of the body. Important Safety Information What is the most im

OVERVIEW

This web site kadcyla.com currently has an average traffic ranking of zero (the lower the superior). We have scanned seventeen pages inside the domain kadcyla.com and found fifteen websites associating themselves with kadcyla.com. There are two contacts and locations for kadcyla.com to help you communicate with them. There are one public communication accounts belong to kadcyla.com. This web site kadcyla.com has been on the internet for seven hundred and ninety-six weeks, seven days, two hours, and twenty-seven minutes.
Pages Crawled
17
Links to this site
15
Contacts
2
Locations
2
Social Links
1
Online Since
Mar 2010

KADCYLA.COM RANKINGS

This web site kadcyla.com has seen diverging quantities of traffic all over the year.
Traffic for kadcyla.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for kadcyla.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for kadcyla.com

Date Range

All time
This Year
Last Year
Last Month

KADCYLA.COM HISTORY

This web site kadcyla.com was registered on March 17, 2010. It was updated on December 23, 2013. This domain will go back on the market on March 17, 2015. It is now seven hundred and ninety-six weeks, seven days, two hours, and twenty-seven minutes old.
REGISTERED
March
2010
UPDATED
December
2013
EXPIRED
March
2015

LENGTH OF LIFE

15
YEARS
3
MONTHS
5
DAYS

LINKS TO WEB SITE

EpatientGRs Blog Με απλά λόγια όσα ήθελες να μάθεις για θέματα υγείας, πολιτικών υγείας, δικαιωμάτων ασθενών άλλα ενδιαφέροντα θέματα της καθημερινής ζωής

Ποιά είναι η epatientGR; Αbout epatientGR. Υγεία και Κοινωνικά Δίκτυα-Healthcare and Social Networks. Αμφισβήτηση δικαιώματος ασθενούς για πρόσβαση στον ιατρικό του φάκελλο. This is the home page widget area. You can use this space to add an introductory message to your blog with a Text Widget or add any other widget here. Ποιά είναι η e-patientGR;. Middot; Tagged with φάκελλος ασθενούς. Πόσο μπορεί να κοστίζει έν.

ImmunoGen Changing Lives

Which is making a difference for people today. Our work changes us - enabling us to use our special skills and expertise to achieve new therapies for people with cancer. A growing number of compounds with our technology are being evaluated in the clinic to treat many different types of cancer.

Matt Gooding Science blog www.mattgooding.com

In order for a tumour to expand larger than about 1 mm. A greater reduction in tumour cell population was observed when the VDA was administered after irradiation, which results in the elimination of hypoxic cells that are resistant to radiotherapy.

WHAT DOES KADCYLA.COM LOOK LIKE?

Desktop Screenshot of kadcyla.com Mobile Screenshot of kadcyla.com Tablet Screenshot of kadcyla.com

CONTACTS

Roche SAS

Piotr Wrzosinski

Grenzacherstrasse 124

Basel, Basel, 4070

CH

International Domain Tech

International Domain Tech

Safenames House, Sunrise Parkway

Milton Keynes, Bucks, MK14 6LS

UK

KADCYLA.COM HOST

Our parsers discovered that a single page on kadcyla.com took two hundred and nineteen milliseconds to load. We discovered a SSL certificate, so we consider this site secure.
Load time
0.219 secs
SSL
SECURE
Internet Protocol
52.52.39.195

NAME SERVERS

hlrns1.roche.com
ns1.roche.com

BROWSER ICON

SERVER OS AND ENCODING

I found that this website is utilizing the Apache operating system.

PAGE TITLE

KADCYLA for previously treated HER2 Metastatic Breast Cancer

DESCRIPTION

Learn about KADCYLA ado-trastuzumab emtansine, a treatment option for HER2-positive breast cancer. Who is KADCYLA for? KADCYLA is approved to treat HER2-positive breast cancer that has spread to other parts of the body metastatic breast cancer after prior treatment with trastuzumab Herceptin and a taxane. Prior treatment could have been for the initial treatment of breast cancer or for the treatment of cancer that had spread to other parts of the body. Important Safety Information What is the most im

CONTENT

This web site kadcyla.com states the following, "KADCYLA and HER2 Metastatic Breast Cancer." We noticed that the website also said " What Is HER2 Metastatic Breast Cancer? How KADCYLA Is Thought To Work." It also said " Talking With Your Healthcare Team. Select Breast Cancer Support Groups. For patients with previously treated HER2 metastatic breast cancer. 2 cancer-fighting agents in 1 drug. With KADCYLA, you receive both a HER2-targeted treatment and a chemotherapy at the same time. How KADCYLA is thought to work."

SEEK SIMILAR DOMAINS

کانون دانش آموختگان بسیجی کاد

فرجام برجام را عاقلانه مدیریت کنیم. از آن زمانی که مقام معظم رهبری مد ظله العالی سخن از بی اعتمادی به امریکا میگفتند مدت زيادي نگذشته است و همگان به خاطر دارند که برخی چگونه در مقابل فرمایشات ایشان لسانا و عملا موضع میگرفتند و از لزو.

KONCEPT ADVERTISING - branding strategie creatie identitate vizuala online marketing fotografie productie publicitara

Branding aniversar si campanie de imagine Aeroport International Cluj-Napoca. Supremia Grup Cataloage Portofoliu de produse. Colorful ideas paired with great visuals. Agentie de creatie si productie publicitara. Good ideas paired with great visuals. Photoshop, Ilustrator, Corel, 3D Studio Max, Flash. Foto de produs, de eveniment. Product photo, aerial photography, virt.

kaddabo reduced to the maximum! DeviantArt

Reduced to the maximum! Reduced to the maximum! Deviant for 9 Years. Reduced to the maximum! April 8, 1989. Reduced to the maximum! This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. The bottom has widgets you can add! .